scispace - formally typeset
Journal ArticleDOI

Value of brush cytology for optimal timing of liver transplantation in primary sclerosing cholangitis.

TLDR
The value of surveillance for dysplasia using brush cytology, to determine the optimal timing of liver transplantation in primary sclerosing cholangitis, is investigated.
Abstract
Background and Aims Primary sclerosing cholangitis (PSC) is associated with a high risk of cholangiocarcinoma (CCA). Here we investigated the value of surveillance for dysplasia using brush cytology, to determine the optimal timing of liver transplantation in PSC. We compared our preoperative findings, with the final explanted liver histopathology. Methods 126 consecutive patients were transplanted for PSC from 1984-2012. Patients were divided into two groups: symptomatic (n = 91), and asymptomatic (n = 35). Results Brush cytology was available for 101 patients; 66 symptomatic and 35 asymptomatic. Suspicious cytological findings were found in 9 patients (14%) in the symptomatic group and 17 (49%) in the asymptomatic group. DNA flow cytometry was available for 49 patients (25 symptomatic, 24 asymptomatic), with aneuploidy detected in six patients (24%) in the symptomatic group and 15 (63%) in the asymptomatic group. Explanted liver histology showed biliary dysplasia or cholangiocarcinoma in 11 symptomatic patients (12%) and 15 asymptomatic patients (43%). A combination of cytological and DNA flow cytometry findings resulted in a test sensitivity of 68%, with a specificity of 86%. Ten-year survival in the asymptomatic group was 91%. Conclusions Dysplasia surveillance using brush specimens may help to select those patients likely to benefit from early liver transplantation. It remains unclear as to whether surveillance with brush cytology improves long-term survival, but there is presently no better method with which to predict transplantation timing. This article is protected by copyright. All rights reserved.

read more

Citations
More filters
Journal ArticleDOI

Anatomical, histomorphological and molecular classification of cholangiocarcinoma.

TL;DR: A main challenge in diagnosing cholangiocarcinoma is the fact that tumour tissue for histological examination is difficult to obtain, a major clinical obstacle is the establishment of the correct diagnosis at a tumour stage that is amenable to surgery which still represents the only curable therapeutic option.
Journal ArticleDOI

EASL Clinical Practice Guidelines on Sclerosing Cholangitis.

TL;DR: Karlsen et al. as mentioned in this paper presented a comprehensive review of the causes of sclerosing cholangitis in adults and children, focusing on secondary causes, and provided guidance on diagnostic methods, prognostic assessment, early detection of complications, optimal care pathways and therapeutic (pharmacological, endoscopic or surgical) options.
Journal ArticleDOI

Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review

TL;DR: More attention should be paid to PSC patients presenting with an abrupt aggravation of jaundice, pain, fatigue, pruritus, weight loss, or worsening liver biochemistries, in particular within the first year after PSC diagnosis.
Journal ArticleDOI

The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis.

TL;DR: Endoscopic retrograde cholangiography has been considered the gold standard for the diagnosis and follow-up of primary sclerosing cholangsitis, but it has been replaced by less invasive magnetic resonance imaging and cholANGiopancreatography, but the role of these two techniques in the evaluation of disease activity and severity needs to be elucidated.
Journal ArticleDOI

Graft glycocalyx degradation in human liver transplantation.

TL;DR: In this paper, a human liver transplantation was studied in human liver, and the results showed that syndecan-1, heparan sulfate and chondroitin sulfate were taken up by the graft during reperfusion.
References
More filters
Journal ArticleDOI

Diagnosis and Management of Primary Sclerosing Cholangitis

TL;DR: Intended for use by physicians, these recommendations suggest preferred approaches to the diagnostic, therapeutic and preventative aspects of care that are intended to be flexible, in contrast to standards of care, which are inflexible policies to be followed in every case.
Journal ArticleDOI

Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma

TL;DR: A better understanding of the imaging characteristics of iCCAs is gained and advanced cytologic techniques to detect pCCAs are developed, along with advances in classification, diagnosis, and treatment.
Journal ArticleDOI

Primary sclerosing cholangitis.

TL;DR: During treatment with UDCA stenoses of major ducts may develop and early endoscopic dilatation is highly effective and in patients with endstage disease, UDCA is not effective and liver transplantation is indicated.
Journal ArticleDOI

Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update

TL;DR: The British Society of Gastroenterology guidelines on the management of cholangiocarcinoma are updated based on a comprehensive review of the recent literature, including data from randomised controlled trials, systematic reviews, meta-analyses, cohort, prospective and retrospective studies.
Journal ArticleDOI

Primary sclerosing cholangitis

TL;DR: The role of environmental factors in generation of lymphocytes that are postulated to be retargeted, deleteriously, to the biliary tree has been investigated in this paper.
Related Papers (5)